Submitted by Anonymous (not verified) on 24 October 2024 - 14:49
Pharmacovigilance Risk Assessment Committee (PRAC): 12 - 15 January 2026, European Medicines Agency, Amsterdam, the Netherlands, from 12 January 2026 to 15 January 2026
Source: